Dr. Prakash Indian Tata

GLP-1 Weight-Loss Injections 2025: Benefits, Risks, and an Ayurvedic View

Introduction In 2025, GLP-1 receptor agonist injections like Semaglutide and Tirzepatide are trending in weight loss circles. These medications are delivering impressive bodyweight reductions—15–20% for some—but medical professionals warn they’re not magic bullets – The Times of India. Dr Prakash Tata advocates for balanced healing, reminding us that modern interventions must complement—not replace—holistic wellness. What […]